Literature DB >> 8957071

Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host.

P D Soloway1, C M Alexander, Z Werb, R Jaenisch.   

Abstract

Timp-1 has been implicated as a suppressor of tumor metastasis. To study the relative importance of Timp-1 expression by tumor vs host during tumor invasion, three pairs of co-isogenic, tumorigenic cells containing wild-type or mutant Timp-1 alleles were generated. These were used in experimental metastasis assays in wild-type or Timp-1-deficient mice. Timp-1 expression in tumorigenic cells could either increase or decrease tumor invasion of lungs in a tumor cell-specific manner. This suggests that depending on the tumor, Timp-1 can either suppress or potentiate metastasis. Mice deficient for Timp-1 were indistinguishable from wild-type mice in metastasis assays with all tumorigenic cells tested. Although Timp-1 is a secreted protein, and lung produces other Timps, the influence of Timp-1 on lung invasion by the tumorigenic cells tested is cell-autonomous, depending only on Timp-1 genotype of tumor and not that of host.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957071

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

Review 1.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis.

Authors:  C Chang; Z Werb
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

3.  Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.

Authors:  Masayuki Shimoda; Simona Principe; Hartland W Jackson; Valbona Luga; Hui Fang; Sam D Molyneux; Yang W Shao; Alison Aiken; Paul D Waterhouse; Christina Karamboulas; Franz M Hess; Takashi Ohtsuka; Yasunori Okada; Laurie Ailles; Andreas Ludwig; Jeffrey L Wrana; Thomas Kislinger; Rama Khokha
Journal:  Nat Cell Biol       Date:  2014-08-24       Impact factor: 28.824

4.  Tissue inhibitor of metalloproteinase 1 regulates resistance to infection.

Authors:  Marie Mei Lee; Bong-June Yoon; Keith Osiewicz; Michael Preston; Brian Bundy; Anna M van Heeckeren; Zena Werb; Paul D Soloway
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 5.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

6.  Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1.

Authors:  Markus Wagner; Vincent Roh; Michael Strehlen; Alexander Laemmle; Deborah Stroka; Bernhard Egger; Markus Trochsler; Kelly K Hunt; Daniel Candinas; Stephan A Vorburger
Journal:  J Gastrointest Surg       Date:  2009-06-30       Impact factor: 3.452

7.  Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.

Authors:  Mark F Sands; Patricia J Ohtake; Supriya D Mahajan; Shervin S Takyar; Ravikumar Aalinkeel; Yisheng V Fang; Jessica W Blume; Barbara A Mullan; Don E Sykes; Sandra Lachina; Paul R Knight; Stanley A Schwartz
Journal:  Clin Immunol       Date:  2008-10-26       Impact factor: 3.969

8.  Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity.

Authors:  Peter Chen; John K McGuire; Robert C Hackman; Kyoung-Hee Kim; Roy A Black; Kurt Poindexter; Wei Yan; Phillip Liu; Ann J Chen; William C Parks; David K Madtes
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

9.  Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells.

Authors:  Patrick J Murphy; Benjamin R Cipriany; Christopher B Wallin; Chan Yang Ju; Kylan Szeto; James A Hagarman; Jaime J Benitez; Harold G Craighead; Paul D Soloway
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

10.  Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors.

Authors:  Alicia Viloria-Petit; Lucile Miquerol; Joanne L Yu; Marina Gertsenstein; Capucine Sheehan; Linda May; Jack Henkin; Corrinne Lobe; Andras Nagy; Robert S Kerbel; Janusz Rak
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.